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Ir-IA is a  dominant autosomal gene(s)  which regulates  the specific antibody response to 
several  antigens,  including  three  branched,  multichain,  polypeptide  antigens,  poly-L- 
(Tyr, Glu)-poly-D,L-Ala--poly-L-Lys; poly-L-(His,  Glu)-poly-D,L-Ala--poly-L-Lys; and  poly- 
L-(Phe,Glu)-poly-D,a-Ala--poly-L-Lys,  abbreviated  respectively  (T,G)-A--L,  (H,G)-A--L, 
and (Phe, G)-A--L (1). 1 The Ir-lA  gene is located within the H-2 region of the mouse, be- 
tween the K  end and another immune response gene, Ir-lB, which in turn maps between 
Ir-lA and the Ss-Slp genes, in the middle of the H-2 region (2-4). 
Adoptive transfer experiments  have demonstrated that the Ir-lA gene is expressed in 
lymphoid cells. Ir-lA-regulated immune responsiveness was found to be transferable with 
lymphocytes  from  high  responder  animals  transferred  into  lethally  irradiated  low 
responder animals (5). The genetic defect in the low responders appears to be expressed in 
thymus-derived  (T)  cells,  as  demonstrated  by  the  following  experiments:  (a)  low 
responder  animals  give  a  normal  immune  response  when  immunized  with  (T,G)-A--L 
coupled to a highly immunogenic carrier such as methylated bovine serum albumin (6, 7); 
(b)  the primary IgM response elicited by aqueous immunization  is equal in high and low 
responder animals, and this primary response is not dependent on the presence of T  cells, 
since  irradiated,  thymectomized,  bone  marrow  reconstituted,  high  and  low  responder 
animals  are  capable  of  a  normal  IgM  response  to  (T,G)-A--L  while  only  the  intact 
responder animals make an IgG secondary response (8, 9); (c) tetraparental mice prepared 
from  high  and  low  responder  embryos  produce  high  amounts  of antibody  of the  low 
responder  allotype  (10).  In  contrast  to  these  results,  limiting  dilution  experiments  of 
Shearer et  al. have suggested that the genetic defect in the response to (Phe,G)-A--L is 
expressed  in  both  T  and  B  cells  (11)  and  that  the  genetic  defect  in  the  response  to 
(T,G)-A--L is  expressed  only in B  cells  (12).  The former data,  and the antigen-specific 
nature  of  the  regulation,  suggest  that  the  Ir-lA  gene-product  is  expressed  on  T 
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lymphocytes and are compatible with the hypothesis that the Ir-lA gene product may be 
the T-cell antigen receptor, or a  part of it,  if it is a  complex structure  (13). 
In  an  effort  to  obtain  more  direct  evidence  on  the  T-cell  expression  of Ir-IA 
regulation,  and to develop methods for preliminary characterization of the gene 
product,  an  in  vitro system  was  established.  Lymphocytes  of in vivo-sensitized 
mice  were  stimulated  with  the  homologous  antigen  in  vitro  and  lymphocyte 
transformation  was  measured  by  [3H]thymidine  uptake.  The  present  report 
describes  experiments  demonstrating  the  T-cell  dependence  of  the  in  vitro 
stimulation  of lymphocytes by  (T,G)-A--L,  (H,G)-A--L, and  (Phe,G)-A--L. The 
requirements  for this  stimulation  have  been  compared  to  the  requirements for 
B-cell stimulation and antigen binding (14), and the blocking activity of different 
altoantisera has  been tested.  A  preliminary report of some of these experiments 
has  been  published elsewhere  (15,  16). 
Materials and Methods 
Animals.  Mice of both  sexes  were  used  at  an  age  of 2~J~-4 mo,  and  were  bred  at  Stanford 
University. The strains,  their origin, H-2 genotype, and responder  status to the three antigens used in 
this study are given in Table I. 
Antigens.  Two  preparations  of  (T,G)-A--L were  used:  (T,G)-A--L-509,  mol  wt  232,000 and 
(T,G)-A--L-52,  mol wt 180,000. One preparation of (H,G)-A--L, was used:  (H,G)-A--L-905  mol wt 
100,000.  (For  more  details  concerning  these  antigens  see  refs.  2,  8,  10). Two  preparations  of 
(Phe,G)-A--L,  were used:  (Phe,G)-A--L-929  and (Phe,G)-A--L-1501  {exact details on the molecular 
weight and residue  molar ratio of these antigens are not yet available). The immunogenicity and 
dependence on Ir-lA genetic  control  of each antigen of the same basic  structure was similar (B. D. 
Deak, in preparation). All antigens were gifts from Dr. Michael Sela, Weizmann Institute, Rehovot, 
Israel. 
Immunization.  The antigens were injected into the hind footpads  of' mice in 0.06 ml complete 
Freund's adjuvant (CFA), or in some experiments, in aqueous  solution.  The dose of the antigen was, 
in the case of (T,G)-A--L,  10 ttg; in the case of (H,G)-A--L,  10 #g; and of (Phe-G)-A--L,  100 ug. Mice 
immunized with antigen in CFA were sacrificed  3 wk after immunization, and mice immunized with 
antigen in aqueous  solution  were sacrificed  1 wk after immunization. 
Source  of Cells.  Experiments were  performed  either with  popliteal and  inguinal lymph node 
cells,  or with  peritoneal exudate lymphocytes (PEL).  The lymph nodes  were trimmed of fat and 
carefully teased with two  pairs  of sharp  forceps  into phosphate-buffered saline (PBS).  Peritoneal 
exudate  cells  (PEC)  were  obtained 3-4 days  after intraperitoneal injection of 3 ml mineral oil by 
flushing the peritoneal cavity with PBS containing 5 U heparin/ml. The exudate was separated from 
TABLE  I 
Inbred Mouse Strains Used, and Their Relevant Characteristics 
H-2  Response to:  Abbre-  Background 
Strain  viation  if congenic  haplo- 
type  (T,G)-A--L  (H,G)-A--L  (Phe,G)-A--L 
C3H.SW  CSW  C3H/DiSn  b  High  Low  High 
C3H.SW-Ig-1 b  CWB  C3H/DiSn  b  High  Low  High 
C3H/DiSn  C3H  --  k  Low  High  High 
C3H.Q  --  C3H/HeJ  q  Low  Low  High 
B10.S  --  C57BL/10Sn  s  Low  Low  Low PETER  LONAI  AND  HUGH  O.  McDEVITT  979 
the  mineral  oil  by  repeated  centrithgation.  At  this  stage  it  contained  approximately  60-75% 
macrophages,  20-30%  lymphocytes,  and  5-10%  eosinophil leukocytes.  The lymphocytes from the 
peritoneal  exudate were purified by filtration through  rayon  wool according to Rosenstreich et al. 
(17). 
Cell Cultures.  In the first half of this study a modification of Tyan's technique was used (18). In 
this modification, 1 million lymph node cells were cultured in no. 2058 Falcon tubes, (Falcon Plastics, 
Div.  of  BioQuest,  Oxnard,  Calif.)  in  l-ml  tissue  culture  medium.  The  medium  was  Tyan's 
modification  of MEM-spinner  medium,  which  was  supplemented  with  glutamine,  nonessential 
amino acids,  sodium  bicarbonate,  streptomycin-penicillin,  and  5% human  serum.  In later experi- 
ments,  Falcon  microtest  II plates  (no.  3040) were used.  1  x  10 ~ cells were  cultured  in  0.2  ml of 
RPMI-1640, supplemented with glutamine, streptomycin-penicillin, and 5% human serum. All tissue 
culture media and reagents were purchased from Grand Island Biological Co., Grand Island,  N. Y. 
The cultures were incubated at 37°C, with 7.5% C02-air mixture, in a humidified incubator, and were 
labeled  for  approximately  16-18  h  before  the  termination  of  the  experiment  with  1  #Ci  of 
[3H]thymidine  (6.7  Ci/mM,  New England  Nuclear,  Boston,  Mass.).  After labeling,  the cells were 
collected on Whatman  glass fiber filters and processed according to Robbins et al. (19).  The filters 
were counted in a toluene, 2-5-diphenyloxazol, 1,4-bis [2-(5-phenyloxazolyl) ]-benzene scintillation mix- 
ture,  in a Beckman liquid scintillation counter (Beckman Instruments,  Inc., Spinco Div., Palo Alto, 
Calif,). For every experimental point, at least three simultaneous cultures were made. The stimulation 
index (S.I.) was calculated as follows: 
"X cpm in the presence of antigen  = S.I. 
cpm in the absence of antigen 
In  several experiments  mitogens other than  the specific antigen  were used.  Phytohaemagglutin-P 
(PHA-P),  pokeweed  mitogen  (PWM),  and  lipopolysaccharide  (LPS)  were  obtained  from  Difco 
Laboratories, Detroit, Mich. For further details of antigen dose and incubation time, please see the 
text. 
Isolation of T Cells.  T cells were isolated from the peritoneal exudates by the nylon wool filtration 
technique (20).  The separation resulted in a population of 80-90% lymphocytes which were 85-95% 
Thy 1.2 positive by cytotoxic titration. The yield was approximately 25-35%  of the initial nucleated 
cell count. 
Antisera.  A  polyvalent  rabbit  antimouse  immunoglobulin  was  kindly  provided  by  Dr.  L.  A. 
Herzenberg, Department of Genetics, Stanford University School of Medicine. The properties of this 
serum have been described previously (21). The anti-H-2q serum (AS-348A)  was produced in (B10.A- 
(5R)  x  LP.RIII)F1 mice against DBA/1 spleen and thymus cells. It contains antibodies to H-2.17 and 
30, which are the K and D private specificities of H-2Q (9). The anti H-2  b serum (AS 598E)  was pro- 
duced in B10.BR x  C3H)F1 mice against C57BL/10Sn cells. Both sera were gifts from Dr. G. D. Snell, 
Jackson Laboratories, Bar Harbor, Maine. To remove potential autoantibodies and nonspecific toxic- 
ity, these sera were adsorbed  with BALB/c (H-2  ~) [ymphocytes. Anti-Thy-l.2 (anti-0  c3~) serum was 
obtained  from  Dr.  U.  H~immerling,  Sloan-Kettering  Memorial  Cancer  Institute,  New  York.  The 
anti-Thy-l.2  serum  was  produced  in  (A0 aKR  x  AKRH-2b)F,  mice against  the  ASL-1 tumor  of A 
origin.  In  this  congenic  combination  the  main  antigenic  difference is the  t~c3H-antigen carried  by 
the tumor cells. 
Results 
Dose-Response Studies.  C3H.Q  mice  were  immunized  with  (Phe,G)-A--L  in 
CFA.  3  wk later,  cultures  were set up in the presence  of 10,  50,  100,  200,  and  400 
ttg  antigen  per  ml.  The  antigen  was  given  at  0  time,  and  the  cultures  were 
incubated  for  4  days.  Fig.  1  shows  that  the  optimal  dose  was  200  ug/ml.  The 
optimal  antigen  dose for (H,G)-A--L  in C3H  mice and for (T,G)-A--L  in C3H.SW 
mice was  determined  in  a  similar  manner.  Fig.  2  demonstrates  that  the optimal 
dose  of  (H,G)-A--L  is  100  ttg/ml.  The  same  dose  was  found  to  be  optimal  for 
(T,G)-A--L.  These  doses  were  used  throughout  our  studies.  The  difference  in 980  GENETIC  CONTROL  OF  THE  IMMUNE  RESPONSE 
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FIG.  1.  Antigen dose  response  curve  for  in  vitro  stimulation with  (Phe,G)-A--L.  C3H.Q 
lymph node lymphocytes from mice immunized with (Phe,G)-A--L in CFA. 
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Fro.  2.  Antigen dose-response curve for in vitro stimulation with  (H,G)-A--L. C3H lymph 
node lymphocytes from mice immunized with (H,G)-A--L in CFA. 
antigen  dose between  (Phe,G)-A--L and  (T,G)-A--L or (H,G)-A--L is  perhaps 
explained by the  higher  molecular weight  of the  latter two.  The optimal dose 
determined by us is in good agreement with the data of Tyan (18). However, we 
did not obtain stimulation values as high as he reports; and in our case no primary 
stimulation was observed. 
The  Kinetics  of the In  Vitro  Response.  30  cultures  were established  from 
lymph node cells of C3H.Q mice immunized with  (Phe,G)-A--L in CFA,  15 of 
them  in the  presence of antigen,  and  15  in  the absence of antigen.  Triplicate 
cultures were processed daily for [3H]thymidine uptake (Fig. 3). The peak of the 
response was on the 4th day of incubation. However, it was apparent that DNA PETER  LONAI  AND  HUGH  O.  McDEVITT 
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FIG. 3.  Kinetics  of  in  vitro  antigen  stimulation.  C3H.Q  lymph  node  cells  from  mice 
immunized with (Phe,G)-A--L in CFA. 
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synthesis  in  cultures  to  which  no  antigen  had  been  added  also  followed an 
upward curve, thus decreasing the stimulation indices. In previous experiments 
(P.  Lonai,  unpublished  data)  it  had  been  shown  that  the  tissue  culture 
supernatant of CFA-immunized lymph node cells, in the first 48 h of cultivation, 
contains a  stimulatory substance. Therefore, an experiment was performed in 
which the cultures were incubated for 24 h in the absence of antigen. After this 
time the tubes were centrifuged, the medium replaced,  and antigen added. In 
this  case,  lower nonstimulated control values,  and  better stimulation indices 
were  obtained  (Fig.  4).  This  experiment  was  performed  with  C3H  mice 
immunized with  (H,G)-A--L in  CFA. In subsequent experiments this method 
was used, except in the case of aqueous immunization, and with PEL cells, where 
no preincubation was required. 
Optimal  Time for Antigen Exposure.  One of the aims of these experiments 
was to test different serological reagents which might be specific for hypothetical 
antigen receptor structures. Ideally, in such blocking experiments, the blocking 
reagent  should  be  present  only for the  time required  for binding the  antigen 
sufficiently for  stimulation,  after  which,  both  the  antigen  and  the  blocking 
reagent should be removed from the system. In this system, initially unbound 
antigen  cannot  stimulate  receptors  which  may  reappear  after  capping  and 
internalization (22). Another advantage of such an approach is that it avoids the 
possible toxic effect of the added serum. To achieve this objective, the following 
experiment was performed: six groups of cultures were established from C3H.Q 
mice immunized with (Phe,G)-A--L. One group was incubated for 5 days in the 
continuous presence of antigen. The other groups were washed and the medium 
was replaced without antigen after different time intervals between 30 min and 982  GENETIC  CONTROL OF  THE  IMMUNE  RESPONSE 
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FIG. 4.  Kinetics of  in  vitro  antigen  stimulation.  The  effect of preincubation  before the 
addition of (H,G)-A--L. C3H lymph node cells from mice immunized with (H,G)-A--L in CFA. 
24 h. It was found (Fig. 5),  that 3-4 h presence of' the antigen in the cultures is 
sufficient for stimulation. This protocol was used in all the blocking experiments. 
The Nature of the Responsive Cell.  In guinea pigs, antigen induced second- 
ary  in  vitro  lymphocyte  transformation  appears  to  be  primarily  a  T-cell 
dependent  function  (23).  In  the  mouse,  this  reaction  is  highly sensitive  to 
anti-Thy-l.2 plus complement. However, Elfenbein and co-workers have demon- 
strated  a  small,  but  significant,  contribution  of  B  cells  in  the  guinea  pig 
lymphocyte proliferation reaction (24).  To obtain an estimate of T-cell depend- 
ency in this system, the following experiments were performed: first, in several 
experiments the cells were pretreated with anti-Thy-l.2 and complement before 
antigenic  stimulation,  in  which  case,  very  low  or  no  in  vitro  response  was 
observed;  second,  to further assess  T-cell  dependency, PEC  from  (T,G)-A--L 
immunized C3H.SW mice were filtered through a nylon wool column according 
to  Julius  et  al.  (20). The  resulting  cell  suspension  was  91%  Thy-l.2 positive. 
These  cells gave a  significant stimulation index in the presence of (T,G)-A--L, 
and the stimulation index could be increased if 5  x  104 unfractionated, nonim- 
mune PEC  were added as a  macrophage source (Fig. 6).  These results suggest 
that the reaction requires no, or only a very small number of B cells; that the reac- 
tion is macrophage dependent; and that the majority of responding cells are thy- 
mus derived. 
The Genetic Regulation of the In  Vitro Response.  The genetic regulation of 
immune  responsiveness  to  the  three  synthetic  antigens  studied  has  been 
characterized mainly by measuring serum antibody levels. In vitro lymphocyte 
stimulation by antigen offers a method for determining whether Ir-lA regulated 
immune responsiveness is  expressed in  a  T-cell response.  Several experiments PETER  LONAI  AND  HUGH  O.  McDEVITT 
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Fro.  6.  In vitro antigen stimulation of purified T  cells. C3H.SW mice were immunized with 
(T,G)-A--L  in  CFA.  The  peritoneal  exudate cells were  removed and T  cells separated  on a 
nylon wool column. M~:5  ×  10 4 peritoneal  exudate cells, unpurified. 
were  performed  in  which  antigen-induced  stimulation  of  lymphocytes  from 
primed high responder and low responder mice was measured in the presence of 
the homologous antigen. A summary of these experiments is shown in Table II. 
The experiments demonstrated that the in vitro system differentiates between 
high and low responder genotypes in the same manner as does in vivo antibody 
production, but apparently to a greater extent, since the cells from low responder 
animals gave no detectable stimulation. 
The Requirement for Metabolic  Activity for Effective  In  Vitro  Stimulation. 984  GENETIC  CONTROL  OF  THE  IMMUNE  RESPONSE 
TABLE II 
H-2-Linked  Immune Responsiveness  to Synthetic Polypeptides 
As Measured  by Secondary In Vitro Stimulation* 
Strain  H-2 
S.I. after primary immunization in 
vivo and stimulation in vitro with: 
(T,G)-A--L  (H,G)-A--L  (Phe,G)-A--L 
CWB  b  12.03  0.98  5.31:~ 
C3H  k  0.99  7.79  2.5:~ 
12.06 
C3H.Q  q  ND  1.15  4.47 
2.575 
B10.S  s  1.125  ND  0.565 
* Data  collected  from three experiments. In every experiment more than 
one strain,  or more than one antigen was used, so that high and low re- 
sponse could be measured within one experiment. 
$ Experiment with PEL cells. 
There are strong indications that antigen binding by T  cells is a  metabolically 
active process. It has been shown that T cells do not bind specifically to cellular 
immunosorbents  (target  cell  monolayers)  (25) at  low  temperatures  or  in  the 
presence of sodium azide (26).  On the other hand, it is well known that B cells 
bind to antigen columns almost equally well at room temperature or in the cold 
(27).  In order to investigate this qualitative difference between antigen binding 
by T  and B  cells at the level of actual stimulation, in the case of a  genetically 
controlled response, the following experiment was performed. Lymphocytes  from 
C3H.Q  mice immunized with (Phe,G)-A--L were stimulated in vitro with the 
homologous antigen. Four groups of cultures were established (Fig. 7). In the first 
group, the cells were exposed to the antigen for 3 h at 37°C and then the cultures 
were washed as  described previously. In the second and third group,  the cells 
were exposed to the antigen at 4°C  for 3 h,  after which time half" of the tubes 
(group 3)  were transferred to 37°C  for an additional 3 h  of incubation, and the 
antigen was removed only after this step. The fburth group was incubated with 
the  antigen for the  full 5  days of the  experiment.  Practically no stimulation 
occurred at 4°C  (Fig. 7)  and incubation in the cold had no deleterious effect on 
the  cultures,  since  an  additional  3  h  incubation  with  antigen  at  37°C  after 
incubation in the cold still  resulted in significant stimulation. Similar results 
were obtained for the temperature dependence of (T,G)-A--L binding by T cells by 
G. J. H~mmerling et al. (14). This study showed that antigen binding by T cells 
is significantly increased at 37°C, as compared to T-cell antigen binding at 4°C. 
However,  B-cell  binding  was  not  influenced  by  temperature  changes.  These 
experiments suggest some type of physiological difference between the antigen 
binding and specific stimulatory processes of T  and B cells. 
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L.  (T,G)-A--L, (H,G)-A--L, and (Phe,G)-A--L are very similar molecules. The 
antibodies  produced against  each  of them  cross-reacts  serologically to a  high 
degree with the other two, but they show no in vivo cross-immunogenicity (28). It 
has been proposed that the B-cell antigen receptor is identical to the immuno- 
globulin produced by the cell (29). If T cells utilize the same antigen receptors, it 
would be expected that T cells from animals sensitized with one of these antigens 
could be stimulated in vitro with the other two. Our experiments show that this is 
not the ease  (Fig. 8).  C3H.Q  mice are  responders only to (Phe,G)-A--L. After 
sensitization in vivo with (Phe,G)-A--L, their cells did not respond to (H,G)-A--L 
in  vitro.  C3H  mice  are  responders  to  both  (H,G)-A--L  and  (Phe, G)-A--L.  If 
the animals were sensitized with (H,G)-A--L, the cells responded in vitro only to 
(H,G)-A--L and not to (Phe,G)-A--L (Fig.  8).  This experiment is also in agree- 
ment  with  those  of  Hiimmerling  et  al.  (4). They  have  shown  that  antigen 
binding by (T,G)-A--L-binding T  cells cannot be blocked by the addition of a 
10-fold  molar  excess  of  (H,G)-A--L  or  (Phe,G)-A--L,  while  B-cell  binding of 
(T,G)-A--L was completely blocked by the addition of a  10-fold  molar excess of 
(H,G)-A--L or  (Phe,G)-A--L. These results again indicate fundamental differ- 
ences between the antigen-binding properties of T  and B lymphocytes. 
Inhibition  of In  Vitro  Stimulation  by AUoantisera.  Because of the  genetic 
linkage between  H-2 and Ir-IA  and  the lack of linkage between H-2 and the 
known immunoglobulin structural genes (2,  7),  the effect of anti-H-2 sera and 
anti-immunoglobulin sera, was studied. The amount of antisera to be used was 
determined in the  following way: for anti-H-2 sera,  a  dose was selected for a 
culture containing 1 ×  l0 s cells which was enough to lyse 5 ×  106 lymphocytes of 
the  appropriate  H-2 genotype in the presence of complement. The polyvalent 986  GENETIC  CONTROL  OF  THE  IMMUNE  RESPONSE 
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anti-immunoglobulin serum was used at a dose which was sufficient for optimal 
staining in indirect immunofluorescence assay of 5  ×  l0 s lymphocytes. 
In the first experiment, the effect of normal BALB/c mouse serum, anti-H-2  q 
serum  and  rabbit  anti-immunoglobulin  serum  was  tested  in different doses on 
C3H.Q  lymph  node  cells  sensitized  with  (Phe,G)-A--L.  The  antigen  and  the 
blocking  sera  were present  in  the  first 4  h  of the  experiment,  alter which  the 
cultures  were  washed  and  incubated  for 5  days  as  described  in  Materials  and 
Methods. As can be seen from Fig. 9, normal mouse serum had no blocking effect 
on the reaction. The anti-H-2 serum significantly inhibited stimulation,  and the 
anti-immunoglobulin  in serum had no inhibitory effect. 
This finding can be interpreted in several ways. It is known that, if T  cells have 
surface  immunoglobulin  (30)  receptors,  they  may be present  in  a  significantly 
lower concentration than  on B  cells  (31,  32).  Therefore, it  could be postulated 
that the lack of inhibition of stimulation by anti-immunoglobulin might be due 
to the lack of these rare specificities in our preparation. In the second half of the 
experiment,  the  effect of' anti-H-2 sera  could be interpreted as  being due to a 
nonspecific  effect.  Thus,  the  inhibition  observed  might  be  the  result  of the 
perturbation  of  the  cell  membrane  by  the  binding  of  large  amounts  of 
alloantisera.  To test  these  possibilities,  the  effect of antibodies  to other T-cell 
surface components was  studied,  and  the inhibitory effect of' the anti-immuno- 
globulin serum was tested on lymphocyte transformation reactions induced by T- 
or B-cell-specific mitogens. 
Thy-l,2 is present in high density on T  cells. If' the blocking effect of anti-H-2 
sera was due only to the perturbation of the membrane by bound antibody, then 
it might be expected that anti-Thy-l.2 sera would have a  similar effect. Fig.  10 
demonstrates  a  representative  experiment.  (Phe,G)-A--L-sensitized  C3H.SW 
cells were stimulated by (Phe,G)-A--L. The reaction was completely inhibited by 
anti-H-2~-serum,  while  the  addition  of anti-Thy-l.2  serum  in  the  absence  of PETER  LONAI  AND  HUGH  O.  McDEVITT  987 
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FIG. 10.  The  effect  of anti-Thy-l,2 serum  on the  in vitro antigen stimulation. C3H.SW 
lymph node cells from mice immunized with (Phe,G)-A--L in CFA. 
complement, had no effect,  suggesting that the inhibitory effect of the anti-H-2 
sera  is not merely a  nonspecific effect and may be the  result of the blocking of 
some structure,  identical with,  cross-reactive with,  or situated near the specific 
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The  effect of the  anti-H-2 and  anti-immunoglobulin  sera  was  also tested  in 
blocking the action of mitogens of known cellular specificity. PHA in soluble form 
is a T-cell stimulant, while PWM primarily stimulates B cells (33, 34). Bacterial 
LPS appears to be an exclusive B-cell mitogen (35). To evaluate the effect of our 
alloantisera  on  stimulation  by  these  mitogens,  the  effect of' anti-H-2q  and  of 
polyvalent anti-Ig  was  studied  on  (Phe,G)-A--L-sensitized  C3H.Q  cells stimu- 
lated  by  (Phe,G)-A--L,  PHA  and  PWM.  Fig.  11  demonstrates  the  inhibitory 
effect of the anti-H-2 serum, and the lack of effect of the anti-Ig serum on specific 
antigen  stimulation.  In  the  same  experiment,  neither  of  the  sera  inhibited 
PHA  stimulation  while  the  anti-immunoglobulin  serum  had  strong,  and  the 
anti-H-2  serum  a  weak  effect  on  PWM  stimulation  of the  same  cells.  The 
experiment demonstrates that the anti-Ig serum does inhibit B-cell proliferation. 
Subsequently, we studied the effect of the alloantisera on B-cell stimulation by 
LPS.  C3H.SW  spleen  cells  were  stimulated  with  LPS  or  PHA.  Anti-Ig  or 
anti-H-2  °  sera  were added  to the  cultures.  It  can  be seen  from Table  III  that 
anti-immunoglobulin  completely  blocks  LPS  stimulation,  while  anti-H-2  has 
only a slight effect. In agreement with former experiments, the two sera had no, 
or only slight,  effect on PHA stimulation. 
These  experiments  suggest  that  the  antibody  binding  to  specific  surface 
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TABLE  III 
The Effect of Polyvalent Anti-Ig Serum and of Anti-H-2 Serum on PHA- and 
LPS-Incluced Stimulation  of C3H.Q Spleen Cells 
989 
Anti-  Inhibi- 
PHA  LPS  Anti-Ig  NMS*  cpm  ±  SD  S.I.  H-2  tion$ 
% 
Exp.  1§ 
Exp. 211 
m 
+ 
+ 
+ 
+ 
-  + 
-  + 
-  + 
-  + 
+ 
+ 
+ 
+ 
÷ 
-  + 
+ 
-  + 
-  -  -  395  74 
+  -  -  524  218 
-  +  -  528  181 
-  -  +  553  69 
-  -  -  7,861  3,073  19.9  -- 
+  -  7,766  4,626  19.6  1.2 
-  +  -  6,894  2,324  17.5  12.3 
-  +  7,801  1,572  19.8  0.8 
-  -  1,104  37  2.8  -- 
+  -  779  74  2.0  29.4 
-  +  -  396  19  1.0  100.0 
-  -  ÷  1,121  52  2.83  0.0 
-  -  -  1,482  380 
+  -  884  128 
-  +  -  1,982  446 
-  -  +  2,142  639 
-  -  32,765  5,236  22.1  -- 
+  -  -  37,693  3,220  25.4  0.0 
-  +  -  26,164  3,806  17.7  20.1 
-  -  ÷  31,523  3,134  21.3  3.8 
-  -  -  11,835  3,841  8.0  -- 
+  9,831  2,043  6.6  16.9 
-  ÷  3,875  685  2.6  67.3 
-  -  +  10,635  1,057  7.2  10.1 
*  Normal  mouse  serum. 
Calculated  from  the  values  of untreated  cultures  respectively  for  each  group. 
§ In  this  experiment  5  ttl  of 1:5  diluted  PHA-P,  50 #g/ml  PS,  15 ttl  of anti-H-2  q,  and  15 t~l  of anti-Ig 
serum  was  used. 
U In this  experiment  10 #l of 1:5 diluted  PHA-P,  100 ug/ml  LPS  and  the  same  amount  of alloantisera 
as  in  Exp.  1  were  used. 
components or cross-reactive or closely situated structures can inhibit lympho- 
cyte  transformation.  H-2  seems  to  be  involved  in  antigen-specific  T-cell 
stimulation.  Immunoglobulins  appear  to  be  involved  in  some  way  in  the 
stimulation  of  B  cells  by  LPS.  This  latter  finding  demonstrates  that  the 
anti-immunoglobulin serum employed does have specificities towards lympho- 
cyte surface  immunoglobulin  involved in  some way  in  LPS  stimulation,  and 
cannot be considered inactive. 990  GENETIC  CONTROL  OF  THE  IMMUNE  RESPONSE 
Discussion 
The  in  vitro  lymphocyte  transformation  system  used  in  these  experiments 
possesses the  antigenic  specificity characteristic  of the Ir-IA  gene(s)  (cf. Table 
II). In  this  system,  antigen  specific  tritiated  thymidine  uptake  appears  to  be 
B-cell  independent,  since  purified  T  cells  exhibit  a  degree  of  responsiveness 
comparable  to  nonpurified  lymph  node  or PEL  cells.  The  fact  that  purified  T 
cells exhibit an in vitro responsiveness which is identical in its specificity to the 
in vivo specificity of the Ir-IA gene indicates  that this gene is expressed in thy- 
mus-derived  immunocompetent  cells.  This  conclusion  is  supported  by several 
ancillary findings.  First, the specificity of antigen recognition in this in vitro sys- 
tem is more precise than  the  binding specificity of humoral antibodies directed 
against  the  three  serologically  cross-reactive  synthetic  antigens  (T,G)-A--L, 
(H,G)-A--L, and  (Phe,G)-A--L (Fig.  8).  Since  T-cell antigen  binding also differ- 
entiates between these three antigens, while B-cell antigen binding does not (14), 
and  since  in  vivo immunogenicity demonstrates  the  same specificity as this  in 
vitro system (28),  these  three  observations together  indicate  that  the specificity 
characteristics  of the Ir-lA  gene(s)  are expressed in thymus-derived cells. Addi- 
tional  support  for  this  conclusion  comes  from  numerous  experiments  demon- 
strating no deficit in specific B-cell function or responsiveness in low responder 
animals  when  immunized  with  the  antigen  coupled  to  a  recognizable  carrier 
molecule  (6-10,  16). 
However, the results presented in these studies do not exclude the concomitant expression 
of Ir-IA gene products in B cells for the following reasons:  (a) primary sensitization may 
require the presence of B cells for adequate T-cell priming; since the response studied is a 
secondary  response,  the  contribution  of B  cells  in  the  primary event leading to T-cell 
sensitization  remains  unknown.  (b)  Shearer,  Mozes,  and  Sela  have  demonstrated  by 
limiting dilution cell transfer experiments that the genetic defect in immune response to 
(T,G)-A--L is a B-cell defect, while that for immune response to (Phe,G)-A--L is expressed 
in both B and T cells (11, 12). The former of these two findings is in disagreement with the 
present  study.  Because of the  different experimental design in these two systems, it is 
difficult  to  determine  what  might have caused  the  difference in  experimental results. 
However, the demonstration that isolated T cells show the same pattern of responsiveness 
and specificity as is shown by in vivo immunization seems to us to support the conclusion 
that the Ir-IA gene(s) is expressed in T  cells. 
The requirement that the cells must be in a state of active metabolism for successful in 
vitro stimulation,  which  was observed in these  experiments  (Fig.  7),  may be a  general 
feature of T-cell interaction  with  antigens.  Specific adherence  of T  cells to  allogeneic 
cellular  immunoabsorbents  (26),  (T,G)-A--L  binding  to  T  cells  (14),  and  in  vitro 
stimulation of T cells by antigen are either decreased or do not occur at low temperatures, 
and are inhibited by sodium azide and sodium nitrite, while antigen binding to B cells is 
not influenced by any of these manipulations. This requirement of T  cells for an active 
metabolic state for optimal interaction with antigen may reflect a fundamental difference 
in  the  nature  of the  T-cell  membrane,  or  in  the  nature  of the  T- and  B-cell  antigen 
receptor, or in the way in which the receptor is incorporated into the cell membrane of the 
respective cell types. PETER  LONAI  AND  HUGH  O.  McDEVITT  991 
The studies on inhibition of in vitro antigen stimulation by alloantisera reported 
here  suggest  either  serological  or topographical  relationship  between antigens 
coded by the H-2 complex and the T-cell antigen receptor.  A direct correlation 
between the  genetic  regulation  of the  immune  response  and  the  specificity of 
blocking  of  antihistocompatibility  sera  on  in  vitro  antigen  stimulation  was 
demonstrated by Shevach and colleagues (36, 37). These authors showed that in 
vitro stimulation of lymphocytes from F1 hybrid guinea pigs derived from strains 
which are responders to two different antigens could be selectively blocked only 
by antihistocompatibility  sera directed against  the histocompatibility antigens 
of the  strain  which  is  a  responder to the  antigen  used for in  vitro lymphocyte 
stimulation  (39). Bluestein (40) showed that intact Ig and (Fab)2 fragments were 
effective in  blocking  in  an  identical  system,  while  active  Fab  monomer  was 
ineffective, indicating that the relationship between histocompatibility antigens 
and T-cell antigen recognition in the guinea pig system is topographical,  rather 
than due to serological cross-reaction or identity. 
The lack of inhibition  of in vitro antigen stimulation by anti-immunoglobulin 
sera  (this  report,  39).suggests  either  that  the  receptor  involved  is  not  an 
immunoglobulin,  or that  it  is an  immunoglobulin  of a  hitherto  unknown  class 
which  does  not  react  with  the  specificities  included  in  our  polyvalent  anti- 
immunoglobulin  sera.  Further  experiments  are  required  for  a  more  precise 
definition of the relationship between components of the major histocompatibil- 
ity  complex  and  specific antigen  recognition.  The  use  of alloantisera  directed 
against  specific  regions  of the  H-2  complex,  including  sera  directed  against 
H-2K, Ia (41), and H-2D, should permit further definition of the relationship of 
these cell surface antigens to T-cell-mediated antigen recognition. 
Summary 
In vitro antigen-induced  tritiated  thymidine uptake has been used to study the 
response of sensitized lymphocytes to (T,G)-A--L, (H,G)-A--L, and (Phe,G)-A--L 
in  responder  and  nonresponder  strains  of  mice.  The  reaction  is  T-cell  and 
macrophage  dependent.  Highly purified T  cells (91% Thy 1.2 positive) are also 
responsive, suggesting that this in vitro lymphocyte transformation system is not 
B-cell dependent. Lymphocytes from high and low responder mice stimulated in 
vitro react as responders and nonresponders  in a  pattern  identical  to that seen 
with in vivo immunization.  Stimulation occurs only if soluble antigen is added at 
physiological  temperatures;  antigen  exposure  at  4°C  followed by washing  and 
incubation  at  37°C  fails to induce  lymphocyte transformation.  Stimulation  is 
specific for the immunizing antigen and does not exhibit the serologic cross-reac- 
tivity which is characteristic of these three antigens and their respective antisera. 
The reaction can be inhibited by anti-H-2 sera but not by anti-immunoglobulin 
sera. The anti-immunoglobulin  sera did,  however, inhibit lipopolysaccharide or 
pokeweed mitogen stimulation.  These results suggest that the Ir-lA gene(s) are 
expressed  in  T  cells,  and  that  there  are  fundamental  physiologic  differences 
between T- and B-cell antigen recognition. 
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